Biphasic anaphylaxis reaction in adult female: how to approach?

Authors

  • Putu A. D. Nirmala Department of Internal Medicine, Wangaya Regional General Hospital, Bali, Indonesia
  • Ketut Suryana Department of Internal Medicine, Merpati Clinic, HIV and Allergy-Immunology Services Unit, Wangaya Hospital, Bali, Indonesia

DOI:

https://doi.org/10.18203/2349-3933.ijam20242316

Keywords:

Anaphylactic reaction, Biphasic anaphylaxis, Allergy

Abstract

Anaphylaxis is a severe allergic reaction, usually occurring one to two hours after exposure to an allergen, that can lead to death. Estimated lifetime prevalence of anaphylaxis is 1.6-5.1%, with global incidence between 50 to 112 episodes per 100.000 persons per year. Biphasic anaphylaxis is a form of recurrent anaphylaxis occurring between 1 to 72 hours after resolution of initial anaphylactic episode. Our case presents an 18-year-old female patient admitted to the emergency department (ED) with chief complaint of shortness of breath and swollen eyes after contact with caterpillar while gardening. General physical examination presented tachycardia, tachypnea, angioedema, urticaria. Localized lung examination presented bilateral wheezing. Patient fulfilled NIAID/FAAN criteria. Patient was administered 0.3 mg epinephrine intramuscular, diphenhydramine injection 10 mg, dexamethasone injection 5 mg, and observed in ED for 1 hour. Patient was then transferred to intensive care unit (ICU) and was in resolution. However, patient presented again with initial symptoms of dyspnea, swollen eyes, and itchiness while under observation. The objective of this paper is to present a rare case of biphasic anaphylaxis and further highlight the importance of awareness to occurrence of biphasic anaphylaxis.

References

Pflipsen MC, Colon KMV. Anaphylaxis: Recognition and Management. 2020. Am Fam Physician;102(6):355-62.

Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M, Fineman S, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13(10):100472.

Turner PJ, Campbell DE, Motosue MS, Campbell RL. Global Trends in Anaphylaxis Epidemiology and Clinical Implications. J Allergy Clin Immunol Pract. 2020;8(4):1169-76.

Pourmand A, Robinson C, Syed W, Mazer-Amirshahi M. Biphasic anaphylaxis: A review of the literature and implications for emergency management. Am J Emerg Med. 2018;36(8):1480-5.

Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082-123.

Yilmaz I, Dogan S, Tutar N, Kanbay A, Buyukoglan H, Demir R. Biphasic anaphylaxis to Gemifloxacin. Asia Pac Allergy. 2012;2:280-2.

Nomura T, Sekii Hajime, Sugita M, Nakahara S. Association between biphasic reactions and the systems of symptoms and treatment in patients with anaphylaxis hospitalized from the emergency department. Acute Med Surg. 2020;7:e599.

Oya S, Nakamori T, Kinoshita H. Incidence and characteristics of biphasic and protracted anaphylaxis: evaluation of 114 inpatients. Acute Med Surg. 2014;1:228-33.

Rohacek M, Edenhofer H, Bircher A, Bingisser R. Biphasic anaphylactic reactions: occurrence and mortality. Allergy. 2014;69:791-7.

Kim TH, Yoon SH, Lee SY, Choi YH, Park CM, Kang HR, et al. Biphasic and protracted anaphylaxis to iodinated contrast media. Eur Radiol. 2018;28:1242-52.

Kraft M, Scherer Hofmeier K, Ruëff F, Pföhler C, Renaudin JM, Bilò MB, et al. Risk Factors and Characteristics of Biphasic Anaphylaxis. J Allergy Clin Immunol Pract. 2020;8(10):3388-95.

Downloads

Published

2024-08-27